Inclusion Criteria : 
   1.  Signed informed consent
   2.  Advanced cancers
   3.  Immune checkpoint inhibitor therapy initiated within +  /  -  2 wks
   4.  Age >  18 y
   5.  ECOG  0 -  3 
   6.  Patient compliant with the study procedures
Exclusion Criteria : 
   1.  Immune checkpoint inhibitor therapy initiated >  2 wks ago
   2.  General vulnerability affecting the participation in the trial
   3.  No internet access